Unimax Chemicals Profile
Key Indicators
- Authorised Capital ₹ 8.00 Cr
as on 24-10-2024
- Paid Up Capital ₹ 6.50 Cr
as on 24-10-2024
- Company Age 39 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 60.97 Cr
as on 24-10-2024
- Satisfied Charges ₹ 1.95 M
as on 24-10-2024
- Revenue -17.69%
(FY 2023)
- Profit -124.48%
(FY 2023)
- Ebitda -183.50%
(FY 2023)
- Net Worth -22.50%
(FY 2023)
- Total Assets -19.95%
(FY 2023)
About Unimax Chemicals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 8.00 Cr and a paid-up capital of Rs 6.50 Cr.
The company currently has active open charges totaling ₹60.97 Cr. The company has closed loans amounting to ₹1.95 M, as per Ministry of Corporate Affairs (MCA) records.
Kaushik Shah, Piyush Shah, and Brijesh Shah serve as directors at the Company.
- CIN/LLPIN
U24239MH1985PTC036332
- Company No.
036332
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 May 1985
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Unimax Chemicals Private Limited offer?
Unimax Chemicals Private Limited offers a wide range of products and services, including Pharma Ingredients & Raw Materials, Antipyretic and Analgesic API.
Who are the key members and board of directors at Unimax Chemicals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Piyush Shah  | Managing Director | 02-May-2001 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kaushik Shah | Director | 24-May-1985 | Current |
| Brijesh Shah | Director | 02-May-2001 | Current |
Financial Performance and Corporate Structure Insights of Unimax Chemicals.
Unimax Chemicals Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 17.69% decrease. The company also saw a substantial fall in profitability, with a 124.48% decrease in profit. The company's net worth observed a substantial decline by a decrease of 22.5%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Unimax Chemicals?
In 2023, Unimax Chemicals had a promoter holding of 15.62% and a public holding of 84.38%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Unimax Laboratories Private LimitedActive 39 years 11 monthsKaushik Shah, Piyush Shah and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 22 Feb 2022 | ₹1.60 Cr | Open |
Others Creation Date: 25 Aug 2020 | ₹9.30 M | Open |
Bank Of Baroda Creation Date: 26 Aug 2008 | ₹5.00 M | Open |
How Many Employees Work at Unimax Chemicals?
Unimax Chemicals has a workforce of 59 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Unimax Chemicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Unimax Chemicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
